1
项与 Human Umbilical Cord Derived Mesenchymal Stem Cells(Chaitanya Hospital) 相关的临床试验 / Unknown status临床1/2期IIT Role of Bone Marrow Derived Autologous Stem Cells + Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Liver Cirrhosis
Cirrhosis is caused by sustained liver damage over several years either by alcohol, viral infection (Hepatitis B, C), a toxic substance (for eg. drugs, excess copper or iron in the liver), or by blockage of biliary system such that the liver undergoes progressive scarring that slowly replaces all of normal liver cells.(LC) represents a late stage of progressive hepatic fibrosis characterized by distortion of the hepatic architecture and formation of regenerative nodules. For this condition of disease the liver transplantation is one of the only effective therapies available ,but due to lack of donors, surgical complications, rejection, and high cost are it's serious problems.
Presently stem cells are used to be a one of the treatment for the same. So our approach is to evaluate the safety and efficacy of mesenchymal stem cell in condition of liver cirrhosis .
100 项与 Human Umbilical Cord Derived Mesenchymal Stem Cells(Chaitanya Hospital) 相关的临床结果
100 项与 Human Umbilical Cord Derived Mesenchymal Stem Cells(Chaitanya Hospital) 相关的转化医学
100 项与 Human Umbilical Cord Derived Mesenchymal Stem Cells(Chaitanya Hospital) 相关的专利(医药)
100 项与 Human Umbilical Cord Derived Mesenchymal Stem Cells(Chaitanya Hospital) 相关的药物交易